Cara Therapeutics CEO Christopher Posner's 2023 pay rises 16% to $2.9M
Cara Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 22, 2024
Cara Therapeutics reported fiscal year 2023 executive compensation information on April 22, 2024.
In 2023, three executives at Cara Therapeutics received on average a compensation package of $1.8M, a 9% decrease compared to previous year.
Average pay of disclosed executives at Cara Therapeutics
Christopher Posner, Chief Executive Officer, received $2.9M in total, which increased by 16% compared to 2022. 61% of Posner's compensation, or $1.8M, was in option awards. Posner also received $415K in non-equity incentive plan, $728K in salary, as well as $11K in other compensation.
Joana Goncalves, Chief Medical Officer, received a compensation package of $1.3M, which decreased by 18% compared to previous year. 45% of the compensation package, or $573K, was in option awards.
Ryan Maynard, Chief Financial Officer, earned $1.2M in 2023, a 34% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2024.